Clinical Trial Update: Lisinopril in Reducing Shortness of Breath Caused by Radiation Therapy in Patients With Lung Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial investigating lisinopril to reduce shortness of breath from radiation therapy in patients with lung cancer has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyspnea
• Non-small Cell Lung Cancer

Drugs mentioned

• Lisinopril (Lisinopril)

Snippet

Sponsor: Mayo Clinic | Conditions: Dyspnea, Non-small Cell Lung Cancer | Phase 2 | Status: COMPLETED | Results posted: 2019-09-17